| New This Week on Process Development Forum |
| |
- Development and Future of Protein A Chromatography Technology: Q&A with Jonathan Royce, GE Healthcare
A discussion of the challenges in the protein A capture step of mAbs, new standards for mAbs purification, costs of protein A steps, and more.
(Read Article)
|
- Patenting Prospects for Cell-Based Therapies
Cell-based therapies are moving medical treatments forward, but intellectual property uncertainties may delay progress. (Read Article)
|
- Current Innovations and Practices to Address Microbial Contamination in Downstream Bioprocessing
A multifaceted, collaborative approach is the key to addressing the multiple challenges of bioburden control. (Read Article)
|
- A Next Generation Protein A Chromatography Resin for Improved Productivity and Bioburden Control
This poster presents a newly designed, high-capacity Protein A resin, MabSelect™ PrismA, which offers alkali stability on par with ion exchange and hydrophobic interaction chromatography resins. (Read Article)
|
| Process Development Forum Topic Spotlight |
| |
|
|
|
|
|
|
|
|
|
GO TO: Process Development Forum
Join the Conversation on LinkedIn |
|
|
|
Questions for 2017
Like what you read? Want to see more of something in particular? Let us know what topics are on your mind and what you'd like to see more of in 2017. |
 |
|
|
